Valiant Organics
Ticker > Company >

Valiant Organics share price

Valiant Organics Ltd.

NSE: VALIANTORG BSE: 540145 SECTOR: Chemicals  95.72 K   320   29

275.00
+29.85 (12.18%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 276.7

Today's Low

₹ 239.8

52 Week High

₹ 508.3

52 Week Low

₹ 225

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 770.54 Cr.

Enterprise Value

₹ 974.46 Cr.

No. of Shares

2.8 Cr.

P/E

35.38

P/B

1.14

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  240.97

CASH

₹ 7.43 Cr.

DEBT

₹ 211.36 Cr.

Promoter Holding

37.89 %

EPS (TTM)

₹  7.77

Sales Growth

6.14%

ROE

-0.45 %

ROCE

2.97%

Profit Growth

1.48 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year6.14%
3 Year-8.83%
5 Year4.26%

Profit Growth

1 Year1.48%
3 Year-130.77%
5 Year-147.51%

ROE%

1 Year-0.45%
3 Year3.67%
5 Year11.09%

ROCE %

1 Year2.97%
3 Year5.62%
5 Year12.43%

Debt/Equity

0.3196

Price to Cash Flow

13.16

Interest Cover Ratio

1.1019

CFO/PAT (5 Yr. Avg.)

1.49651981533302

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2025 37.89 0.00
Sep 2025 37.91 0.00
Jun 2025 37.91 0.00
Mar 2025 37.91 0.00
Dec 2024 37.74 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 7.86709999999999 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.49651981533302.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 7.61530905711777.

 Limitations

  • The company has shown a poor profit growth of -130.768358924447% for the Past 3 years.
  • The company has shown a poor revenue growth of -8.8288018030014% for the Past 3 years.
  • Company has a poor ROE of 3.6712% over the past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Net Sales 160.18 186.86 203.81 204.41 157.21
Total Expenditure 157.81 171.53 183.52 179.58 136.05
Operating Profit 2.36 15.33 20.29 24.83 21.16
Other Income 2.02 5.04 0.67 1.07 0.2
Interest 8.25 5.83 4.65 6 4.21
Depreciation 8.79 8.99 9.2 9.42 9.78
Exceptional Items 0 0 0 0 0
Profit Before Tax -12.65 5.55 7.11 10.48 7.36
Tax -1.5 0.91 3.15 2.91 1.76
Profit After Tax -11.16 4.65 3.96 7.58 5.6
Adjusted EPS (Rs) -4.04 1.68 1.41 2.71 2

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 574.24 948.45 911.62 677.19 718.76
Total Expenditure 416.98 783.41 781.63 638.07 665.21
Operating Profit 157.26 165.04 129.99 39.12 53.56
Other Income 16.9 5.56 2.92 3.34 8.25
Interest 3.49 6.35 10.54 19.38 23.64
Depreciation 18.63 27.29 27.63 33.97 35.76
Exceptional Items 0 0 4.9 5.75 0
Profit Before Tax 152.04 136.95 99.64 -5.14 2.41
Tax 37.45 34.01 24.07 -2.1 5.41
Net Profit 114.59 102.94 75.58 -3.04 -3
Adjusted EPS (Rs.) 42.2 37.91 27.83 -1.1 -1.07

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 27.94 27.56 27.56 27.58 28
Total Reserves 474.74 575.57 638.48 637.3 633.61
Borrowings 74.71 93.97 58.86 74.16 50.69
Other N/C liabilities 21.44 27.46 34.35 32.92 38.13
Current liabilities 206.74 358.32 346.55 370.32 328.88
Total Liabilities 805.58 1082.88 1105.79 1142.28 1079.32
Assets
Net Block 477.57 508.88 609.8 630.49 644.49
Capital WIP 45.89 110.16 70.2 86.14 65.7
Intangible WIP 0 0 0 0 0
Investments 41.83 53.35 52.6 54.17 54.08
Loans & Advances 14.55 6.35 9.79 10.99 10.72
Other N/C Assets 0 0 0 0.06 0.05
Current Assets 225.73 404.14 363.4 360.44 304.28
Total Assets 805.58 1082.88 1105.79 1142.28 1079.32
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 152.04 136.95 94.75 -10.89 2.41
Adjustment 6.96 32.48 40.69 51.67 56.93
Changes in Assets & Liabilities -11.73 -152.98 64.68 45.52 -0.78
Tax Paid -32.7 -27.61 -17.57 -1.21 0
Operating Cash Flow 114.57 -11.17 182.54 85.09 58.56
Investing Cash Flow -135.38 -120.11 -90.63 -65.03 -27.06
Financing Cash Flow 21.89 145.61 -108.61 -23.12 -27.65
Net Cash Flow 1.08 14.34 -16.7 -3.05 3.85

Corporate Actions

Investors Details

PARTICULARS Dec 2024% Mar 2025% Jun 2025% Sep 2025% Dec 2025%
promoters 37.74 37.91 37.91 37.91 37.89
aakansha pharmachem llp 0.02 0.02 0.02 0.02 0.02
aarti corporate services ... 0.37 0.37 0.37 0.37 0.37
alchemie financial servic... 0.20 0.20 0.20 0.20 0.20
alchemie finserv pvt. ltd... 0.13 - 0.13 0.13 0.13
arti rajendra gogri 7.17 7.06 7.06 7.06 7.06
arvind kanji chheda 1.57 1.55 1.55 1.55 1.55
chandrakant vallabhaji go... 0.30 0.30 0.30 0.30 0.30
dhanvanti hemchand gala 0.18 0.18 0.18 0.18 0.18
dilesh roadlines pvt ltd 2.23 - 2.85 2.85 2.85
drl cargo carriers pvt lt... 0.06 - 0.11 0.11 0.11
hemchand lalji gala 0.42 0.42 0.42 0.42 0.42
hetal gogri gala 0.91 0.89 0.89 0.89 0.89
hiral arvind chheda 1.47 1.45 1.45 1.45 1.45
indira madan dedhia 0.13 0.13 0.13 0.13 0.13
jaya chandrakant gogri 8.37 8.25 8.25 8.25 8.24
manisha rashesh gogri 5.76 5.67 5.67 5.67 5.67
mirik rajendra gogri 2.43 2.39 2.39 2.39 2.39
paridhi business trust (s... - - 0.46 0.46 0.46
pooja renil gogri 0.21 0.20 0.20 0.20 0.20
tulip family trust (gloir... - - 2.19 2.19 2.18
ujjwal business trust (al... - - 2.14 2.14 2.14
vicky hemchand gala 0.94 0.92 0.92 0.92 0.92
alabhya trusteeship priva... 2.17 2.14 - - -
alchemie finserv private ... - 0.13 - - -
dilesh roadlines private ... - 2.85 - - -
drl cargo carriers privat... - 0.11 - - -
gloire trusteeship servic... 2.22 2.19 - - -
saswat trusteeship privat... 0.47 0.46 - - -
PARTICULARS Dec 2024% Mar 2025% Jun 2025% Sep 2025% Dec 2025%
investors 62.26 62.09 62.09 62.09 62.11
bhanumati mohanlal savla 3.30 3.24 3.19 3.19 3.19
bhavesh dhirajlal sheth 1.22 1.21 1.21 1.21 1.21
bhaveshkumar bachubhai me... 2.24 2.29 2.29 2.29 2.29
harsha mahesh savadia 2.34 2.30 2.30 2.30 2.30
llp 0.04 0.09 0.10 0.11 0.11
mahesh mathuradas savadia... 1.95 1.92 1.92 1.92 1.92
meena manoj chheda 1.96 1.93 1.93 1.93 1.93
nikhil parimal desai 9.10 9.17 9.17 9.17 9.16
nipun harihar bhatt 1.07 - 1.06 1.06 1.06
nipun harihar bhat - 1.06 - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
Research Monarch Networth Capital
Research Monarch Networth Capital
Research Monarch Networth Capital
Research Monarch Networth Capital
Research Monarch Networth Capital

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY23
Concall Q4FY22
Concall Q3FY24
Concall Q1FY23
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY22
Presentation Q4FY22
Presentation Q3FY24
Presentation Q3FY23
Presentation Q3FY22
Presentation Q3FY22
Presentation Q3FY22
Presentation Q2FY23
Presentation Q1FY26
Presentation Q1FY25
Presentation Q1FY25
Presentation Q1FY24

Company News

Valiant Organics informs about trading window closure 26 Dec, 3:31 PM Valiant Organics informs about newspaper clippings 15 Nov, 2:56 PM Valiant Organics - Quaterly Results 13 Aug, 5:07 PM Valiant Organics - Quaterly Results 13 Aug, 5:07 PM Valiant Organics - Quaterly Results 13 Aug, 5:07 PM Valiant Organics informs about compliance certificate 9 Jul, 4:52 PM Valiant Organics - Quaterly Results 22 May, 8:14 PM Valiant Organics - Quaterly Results 22 May, 8:14 PM Valiant Organics inks pact to acquire 26.25% stake in Pro-Zeal Green Power Eight 24 Apr, 4:00 PM Valiant Organics informs about certificate 5 Apr, 12:12 PM Valiant Organics - Quaterly Results 13 Feb, 5:16 PM Valiant Organics - Quaterly Results 13 Feb, 5:16 PM Valiant Organics submits board meeting intimation 6 Feb, 1:03 PM Valiant Organics informs about re-commencement of operations 20 Jan, 5:29 PM Valiant Organics informs about voting results of postal ballot 2 Jan, 5:24 PM Valiant Organics informs about investor presentation 3 Dec, 5:06 PM Valiant Organics informs about newspaper advertisement 3 Dec, 12:54 PM Valiant Organics - Quaterly Results 13 Aug, 6:52 PM Valiant Organics informs about investor presentation 17 Jun, 4:41 PM Valiant Organics - Quaterly Results 24 May, 9:37 PM Valiant Organics - Quaterly Results 24 May, 9:37 PM Valiant Organics informs about certificate 4 Apr, 5:32 PM Valiant Organics - Quaterly Results 13 Feb, 4:09 PM Valiant Organics - Quaterly Results 13 Feb, 4:09 PM Valiant Organics informs about earnings call transcript 16 Nov, 12:50 PM Valiant Organics informs about press release 10 Nov, 3:15 PM Valiant Organics informs about financial results 8 Nov, 5:01 PM Valiant Organics - Quaterly Results 8 Nov, 4:35 PM Valiant Organics - Quaterly Results 9 Aug, 4:43 PM Valiant Organics - Quaterly Results 9 Aug, 4:43 PM Valiant Organics - Quaterly Results 9 Aug, 4:43 PM Valiant Organics - Quaterly Results 19 May, 6:28 PM Valiant Organics - Quaterly Results 19 May, 6:28 PM Valiant Organics - Quaterly Results 31 Jan, 4:18 PM Valiant Organics - Quaterly Results 31 Jan, 4:18 PM Valiant Organics - Quaterly Results 31 Jan, 4:18 PM Valiant Organics - Quaterly Results 8 Nov, 2:43 PM Valiant Organics - Quaterly Results 8 Nov, 2:43 PM Valiant Organics - Quaterly Results 8 Nov, 2:43 PM Valiant Organics informs about analyst meet 29 Aug, 12:29 PM Valiant Organics informs about audio recording 8 Aug, 4:52 PM Valiant Organics informs about newspaper publication 6 Aug, 12:31 PM Valiant Organics - Quaterly Results 4 Aug, 6:28 PM Valiant Organics - Quaterly Results 4 Aug, 6:28 PM Valiant Organics - Quaterly Results 4 Aug, 6:28 PM Valiant Organics informs about board meeting 27 Jul, 5:00 PM Valiant Organics incorporates wholly owned subsidiary 11 Jul, 5:21 PM Valiant Organics - Quaterly Results 25 May, 8:32 PM Valiant Organics - Quaterly Results 25 May, 8:32 PM Valiant Organics informs about disclosure 5 Mar, 4:13 PM

Valiant Organics Stock Price Analysis and Quick Research Report. Is Valiant Organics an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Valiant Organics. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Valiant Organics has a PE ratio of 35.079840961437 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Valiant Organics has ROA of -0.2699% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Valiant Organics has a Current ratio of 0.9252.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Valiant Organics has a ROE of -0.4524%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Valiant Organics has a Debt to Equity ratio of 0.3196 which means that the company has low proportion of debt in its capital.

  • Sales growth: Valiant Organics has reported revenue growth of 6.1385% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Valiant Organics for the current financial year is 7.45107767274218%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Valiant Organics is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Valiant Organics is Rs 7.7717. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Valiant Organics in Ticker for free. Also, one can get the intrinsic value of Valiant Organics by using Valuation Calculators, which are available with a Finology ONE subscription. 

Valiant Organics FAQs

Q1. What is Valiant Organics share price today?
Ans: The current share price of Valiant Organics is Rs 272.63.

Q2. What is the market capitalisation of Valiant Organics?
Ans: Valiant Organics has a market capitalisation of Rs 763.89862743 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Valiant Organics?
Ans: The PE ratio of Valiant Organics is 35.079840961437 and the P/B ratio of Valiant Organics is 1.13136874744785, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Valiant Organics share?
Ans: The 52-week high share price of Valiant Organics is Rs 507.8, and the 52-week low share price of Valiant Organics is Rs 226.

Q5. Does Valiant Organics pay dividends?
Ans: Currently, Valiant Organics does not pay dividends. Dividend yield of Valiant Organics is around 0%.

Q6. What are the face value and book value of Valiant Organics shares?
Ans: The face value of Valiant Organics shares is Rs 10, while the book value per share of Valiant Organics is around Rs 240.9736. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Valiant Organics?
Ans: Valiant Organics has a total debt of Rs 211.3569 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Valiant Organics?
Ans: The ROE of Valiant Organics is -0.4524% and ROCE of Valiant Organics is 2.9718%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Valiant Organics a good buy for the long term?
Ans: The Valiant Organics long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Valiant Organics undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Valiant Organics appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Valiant Organics’s financials?
Ans: You can review Valiant Organics’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Valiant Organics

Valiant Organics Limited Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Valiant Organics Limited, a renowned name in the chemical industry, is a leading manufacturer of specialty chemicals and intermediates. The company was founded in [year] and has since achieved remarkable growth and success. With its commitment to quality and innovation, Valiant Organics has established itself as a reliable and trusted player in the market.

Valiant Organics Limited: Share Price

The stock price of Valiant Organics Limited reflects the market value of the company's shares. As a long-term stock investor, understanding the trends and movements of the share price is crucial. Our pre-built screening tools provide insightful analysis, enabling investors to make informed decisions based on historical and current share price data.

Valiant Organics Limited: Balance Sheet

Valiant Organics Limited's balance sheet provides a snapshot of the company's financial position. It showcases the company's assets, liabilities, and shareholders' equity. Utilizing our premium features, such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, investors can accurately assess the company's financial health and fair value.

Valiant Organics Limited: Annual Report

Valiant Organics Limited's annual report serves as a comprehensive overview of the company's performance over the year. Our website offers downloadable annual reports that provide detailed information about the company's operations, financial statements, management discussions, and analysis. These reports are vital resources for conducting thorough stock analysis.

Valiant Organics Limited: Dividend

Dividends are an important aspect for long-term stock investors seeking reliable returns. Valiant Organics Limited's dividend policy rewards its shareholders with regular payouts, reflecting the company's financial stability and profitability. By analyzing the company's dividend history and payout ratio, investors can evaluate the potential value of owning Valiant Organics' stock.

Valiant Organics Limited: Quarterly Result

Analyzing Valiant Organics Limited's quarterly results aids investors in tracking the company's performance on a shorter timeframe. Our platform offers easy access to quarterly reports, allowing investors to monitor important financial metrics, such as revenue, net income, and operating margins. This information facilitates a comprehensive evaluation of the company's financial standing.

Valiant Organics Limited: Stock Price

The stock price of Valiant Organics Limited is influenced by various factors, including market demand, industry trends, and company performance. By utilizing our pre-built screening tools and price charts, investors can track stock price movements, identify patterns, and make informed decisions regarding their investment strategies.

Valiant Organics Limited: Price Chart

Our website provides detailed stock price charts, allowing investors to visualize the trends and patterns in Valiant Organics Limited's stock price over different time periods. Price charts aid in identifying support and resistance levels, trend reversals, and potential entry or exit points. This data assists long-term investors in making well-informed investment decisions.

Valiant Organics Limited: News

Keeping up with the latest news and updates related to Valiant Organics Limited is crucial for understanding the factors that can impact the company's stock performance. Our platform offers a curated news section that provides timely and relevant information, helping investors stay informed and make informed decisions based on the latest developments.

Valiant Organics Limited: Concall Transcripts

Concall transcripts provide valuable insights into the discussions and decisions made during company conference calls with analysts and investors. Our website offers downloadable concall transcripts, making it convenient for investors to access and analyze the key takeaways from these discussions. These transcripts assist investors in understanding management strategies, growth plans, and key risks associated with Valiant Organics Limited.

Valiant Organics Limited: Investor Presentations

Investor presentations provide a comprehensive overview of Valiant Organics Limited's business strategy, operations, financial performance, and growth prospects. Our website offers downloadable investor presentations, allowing investors to delve deeper into the company's strategic initiatives, sector analysis, and competitive positioning. These presentations serve as valuable resources for long-term investors conducting thorough stock analysis.

Valiant Organics Limited: Promoters

The promoters of Valiant Organics Limited are key stakeholders who have a significant influence on the company's operations and decision-making processes. Our website provides information about the promoters, their background, and their contribution to the company's success. Understanding the promoters' track record and vision provides investors with valuable insights into the company's long-term prospects.

Valiant Organics Limited: Shareholders

Valiant Organics Limited's shareholders are an essential part of the company's ownership structure. Our website offers insights into the major shareholders, including institutional investors and retail investors. Monitoring changes in the shareholder base can provide investors with valuable information about market sentiment, investor confidence, and potential future developments.

Please note that all the relevant resources, such as annual reports, concall transcripts, investor presentations, and research reports, are provided as downloadable files on our website. These resources, combined with our pre-built screening tools and premium features, empower investors to conduct comprehensive stock analysis and make informed investment decisions for long-term success. 

Valiant Organics Reserves Analysis

Reviewing the balance sheet of Valiant Organics, we see a steady increase in total reserves from Rs 373.58 Cr in March 2020 to Rs 637.30 Cr in March 2024. This indicates a consistent retention of profits and a strengthening financial reserve base over the years.

Valiant Organics Debt Situation

The borrowings of Valiant Organics have undergone fluctuations, peaking at Rs 93.97 Cr in March 2022 before reducing to Rs 74.16 Cr by March 2024. This reflects the company's dynamic approach to managing its debt.

Valiant Organics Asset Growth

Valiant Organics has shown considerable growth in its asset base from Rs 629.02 Cr in March 2020 to Rs 1,142.28 Cr in March 2024. The net block, which is a significant component of the company's assets, has increased from Rs 255.65 Cr to Rs 630.49 Cr, suggesting considerable capital asset investments.

Valiant Organics Current Liabilities

The company's current liabilities have witnessed a growth, reaching Rs 371.90 Cr in March 2024, up from Rs 145.64 Cr in March 2020. This points to an increase in short-term financial obligations.

Valiant Organics Equity Structure

The share capital of Valiant Organics shows minimal changes, with a slight increase to Rs 27.58 Cr in March 2024 from Rs 14.37 Cr in March 2020. This indicates stability in the company's equity funding.

The data presented is an analysis for the Standalone Balance Sheet of Valiant Organics.

With Valiant Organics' steady growth, investors and market analysts monitoring NSE/BSE indices should consider these financial insights when assessing sector performance.

Read More
X